DexCom (NASDAQ:DXCM) Posts Quarterly Earnings Results, Beat

DexCom (NASDAQ:DXCM – Get Rating) released its earnings results on Thursday. The medical device company reported $0.17 EPS for the quarter, beating the consensus estimate of $0.15 by $0.02, Briefing.com reports. DexCom had a net margin of 9.68% and a return on equity of 18.65%. The business had revenue of $7.45 billion during the quarter, […]

Related Keywords

Manhattan , New York , United States , Steven Robert Pacelli , Raymond James , Stifel Nicolaus , Jacob Steven Leach , Money Concepts Capital Corp , Morgan Stanley , Kb Financial Partners , Barclays , Atlas Capital Advisors , First Manhattan Co , Dexcom Inc , Group Wealth Management , Get Rating , Com Stock Down , Director Steven Robert Pacelli , Steven Leach , Capital Advisors , Wealth Management , Concepts Capital Corp , Dexcom Daily , Dexcom , Nasdaq Dxcm , Dxcm , Medical , 25213110 , Earnings ,